Physician
University of Utah Community Physicians Group
University of Utah Community Physicians Group was paid $35.94M by Medicaid between Jan 2018 and Dec 2024, across 89 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 61% of everything it billed.
33Billing provider infoUNIVERSITY OF UTAH COMMUNITY PHYSICIANS GROUP
SALT LAKE CITY, UT 84119
SALT LAKE CITY, UT 84119
33aNPI1124422126assigned 10/20/2014
33bProvider typeGeneral Practice Physician
28Total paid$35.94M
24GClaims529,815
24DCodes billed89
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Utah
Rank by total paid#2 of 11
Median peer was paid$519K
This provider vs. median69×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FINLAYSON, SAMUEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,370 | $3.72M | |
| 2019 | 55,675 | $3.54M | |
| 2020 | 53,423 | $3.86M | |
| 2021 | 73,757 | $5.67M | |
| 2022 | 81,949 | $6.16M | |
| 2023 | 87,458 | $6.20M | |
| 2024incomplete | 116,183 | $6.79M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 61% | 302,700 | 261,999 | $21.97M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 83,388 | 77,757 | $4.60M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.0% | 21,156 | 20,513 | $2.16M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.7% | 24,929 | 24,073 | $1.69M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.3% | 15,474 | 14,093 | $1.53M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.8% | 12,651 | 12,500 | $989K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.1% | 10,825 | 10,527 | $769K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.5% | 7,189 | 7,118 | $553K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,030 | 3,949 | $336K |
| 99205 | Prolong outpt/office vis | <1% | 942 | 926 | $124K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,168 | 1,056 | $111K |
| 99381 | <1% | 1,454 | 1,384 | $109K |
77 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,375 | $104K |
| 99383 | <1% | 1,040 | $85K | |
| 99384 | <1% | 886 | $80K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 943 | $77K |
| 99493 | <1% | 606 | $59K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,475 | $52K |
| 99385 | <1% | 507 | $43K | |
| 99382 | <1% | 472 | $37K | |
| 86480 | <1% | 539 | $31K | |
| 91320 | <1% | 295 | $21K | |
| 99417 | Prolong home eval add 15m | <1% | 931 | $20K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 626 | $20K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 533 | $20K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 531 | $20K |
| 99386 | <1% | 194 | $19K | |
| 99492 | <1% | 171 | $18K | |
| 99495 | <1% | 183 | $18K | |
| 17110 | <1% | 270 | $18K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 13,246 | $16K |
| 99496 | <1% | 99 | $14K | |
| 10060 | <1% | 178 | $13K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,401 | $11K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 574 | $10K |
| 99421 | <1% | 576 | $9K | |
| 86803 | <1% | 642 | $9K | |
| 99494 | <1% | 162 | $9K | |
| 86704 | <1% | 578 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 719 | $8K |
| 69210 | <1% | 462 | $8K | |
| 90739 | <1% | 61 | $8K | |
| 11721 | <1% | 1,058 | $8K | |
| 90480 | <1% | 248 | $7K | |
| 87340 | <1% | 549 | $7K | |
| 80305 | <1% | 359 | $6K | |
| 86708 | <1% | 414 | $6K | |
| 86787 | <1% | 381 | $6K | |
| 86706 | <1% | 580 | $6K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 307 | $6K |
| 99490 | Ccm add 20min | <1% | 179 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 245 | $5K |
| 80053 | Comprehensive metabolic panel | <1% | 579 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 911 | $5K |
| 12001 | <1% | 86 | $4K | |
| 90715 | <1% | 132 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 410 | $4K |
| 11720 | <1% | 606 | $4K | |
| 80061 | Lipid panel | <1% | 231 | $3K |
| 31720 | <1% | 142 | $3K | |
| 11750 | <1% | 34 | $3K | |
| 99188 | <1% | 1,117 | $3K | |
| 90713 | <1% | 80 | $3K | |
| 20610 | <1% | 79 | $2K | |
| 83655 | <1% | 188 | $2K | |
| 86682 | <1% | 237 | $2K | |
| 90686 | <1% | 207 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 360 | $2K |
| 81002 | <1% | 683 | $2K | |
| 86592 | <1% | 474 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 146 | $2K |
| 58300 | <1% | 28 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 236 | $2K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 30 | $2K |
| 90656 | <1% | 114 | $1K | |
| 81025 | <1% | 184 | $1K | |
| 11981 | <1% | 13 | $977.50 | |
| 81001 | <1% | 334 | $933.72 | |
| 87207 | <1% | 86 | $908.87 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 200 | $889.06 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 138 | $583.73 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 47 | $386.32 |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 24 | $148.89 |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 15 | $145.44 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 68 | $101.54 |
| 77080 | <1% | 14 | $100.49 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 27 | $38.75 |
| 11719 | <1% | 31 | $25.83 | |
| 99441 | <1% | 23 | $1.55 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFINLAYSON, SAMUEL (CHIEF CLINICAL OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.